Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Long-Term Debt Repayments (2016 - 2025)

HealthLynked (HLYK) has disclosed Long-Term Debt Repayments for 10 consecutive years, with $189999.0 as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 39.83% to $189999.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $536065.0, a 55.48% decrease, with the full-year FY2024 number at $941660.0, down 14.13% from a year prior.
  • Long-Term Debt Repayments was $189999.0 for Q3 2025 at HealthLynked, up from $119533.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $377438.0 in Q4 2023 to a low of $51109.0 in Q1 2021.
  • A 5-year average of $193138.4 and a median of $178515.5 in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: plummeted 86.3% in 2021, then soared 529.29% in 2023.
  • HealthLynked's Long-Term Debt Repayments stood at $51109.0 in 2021, then skyrocketed by 171.37% to $138693.0 in 2022, then skyrocketed by 172.14% to $377438.0 in 2023, then tumbled by 69.5% to $115115.0 in 2024, then skyrocketed by 65.05% to $189999.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Long-Term Debt Repayments are $189999.0 (Q3 2025), $119533.0 (Q2 2025), and $111418.0 (Q1 2025).